Synthesis and Anti-herpetic Activity of Phosphoramidate ProTides

ChemMedChem

Volumn 8, Issue 6, 2013, Pages 985-993

  Maiti, Munmun ^a   Persoons, Leentje ^a   Andrei, Graciela ^a   Snoeck, Robert ^a   Balzarini, Jan ^a   Herdewijn, Piet ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral agents; Drug delivery; Nucleosides; Phosphoramidates; Protecting groups

Indexed keywords

NUCLEOSIDE ANALOG; PHOSPHORAMIDIC ACID DERIVATIVE; PRODRUG; THYMIDINE KINASE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; HUMAN; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS;

AMIDES; ANTIVIRAL AGENTS; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; HERPESVIRUS 1, HUMAN; HERPESVIRUS 3, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHOSPHORIC ACIDS; PRODRUGS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84878348879     PISSN: 18607179     EISSN: 18607187     Source Type: Journal    
DOI: 10.1002/cmdc.201300035     Document Type: Article

References (49)

1. E. DeClercq, Adv. Virus Res. 2009, 73, 1-53;
2. G. Antonelli, O. Turriziani, Int. J. Antimicrob. Agents 2012, 40, 95-102.
3. E. DeClercq, Med. Res. Rev. 2005, 25, 1-20.
4. H. S. Allaudeen, J. W. Kozarich, J. R. Bertino, E. DeClercq, Proc. Natl. Acad. Sci. USA 1981, 78, 2698-2702.
5. J. A. Fyfe, Mol. Pharmacol. 1982, 21, 432-437.
6. J. Balzarini, Pharm. World Sci. 1994, 16, 113-126;
7. C. R. Wagner, S. L. Chang, G. W. Griesgraber, H. Song, E. J. McIntee, C. L. Zimmerman, Nucleosides Nucleotides 1999, 18, 913-919;
8. S. Chang, G. W. Griesgraber, P. J. Southern, C. R. Wagner, J. Med. Chem. 2001, 44, 223-231.
9. J. Balzarini, H. Egberink, K. Hartmann, D. Cahard, T. Vahlenkamp, H. Thormar, E. DeClercq, C. McGuigan, Mol. Pharmacol. 1996, 50, 1207-1213.
10. B. A. J. Wilber, J. J. Docherty, J. Gen. Virol. 1994, 75, 1743-1747.
11. C. R. Wagner, V. V. Iyer, E. J. McIntee, Med. Res. Rev. 2000, 20, 417-451.
12. K. G. Devine, C. McGuigan, T. J. O'Connor, S. R. Nicholls, D. Kinchington, AIDS 1990, 4, 371-373.
13. D. Cahard, C. McGuigan, J. Balzarini, Mini Rev. Med. Chem. 2004, 4, 371-381.
14. D. P. Drontle, C. R. Wagner, Mini Rev. Med. Chem. 2004, 4, 409-419.
15. Y. Mehellou, J. Balzarini, C. McGuigan, ChemMedChem 2009, 4, 1779-1791.
16. S. A. Harris, C. McGuigan, G. Andrei, R. Snoeck, E. DeClercq, J. Balzarini, Antiviral Chem. Chemother. 2001, 12, 293-300.
17. A. Giraut, X. P. Song, M. Froeyen, P. Marliere, P. Herdewijn, Nucleic Acids Res. 2010, 38, 2541-2550.
18. D. Farquhar, D. N. Srivastva, N. J. Kattesch, P. P. Saunders, J. Pharm. Sci. 1983, 72, 324-325.
19. L. Naesens, N. Bischofberger, P. Augustijns, P. Annaert, G. van den Mooter, M. N. Arimilli, C. U. Kim, E. DeClercq, Antimicrob. Agents Chemother. 1998, 42, 1568-1573;
20. H. B. Fung, E. A. Stone, F. J. Piacenti, Clin. Ther. 2002, 24, 1515-1548.
21. J. E. Starrett, Jr., D. R. Tortolani, M. J. Hitchcock, J. C. Martin, M. M. Mansuri, Antiviral Res. 1992, 19, 267-273;
22. L. Naesens, J. Balzarini, N. Bischofberger, E. DeClercq, Antimicrob. Agents Chemother. 1996, 40, 22-28;
23. P. Annaert, R. Kinget, L. Naesens, E. DeClercq, P. Augustijns, Pharm. Res. 1997, 14, 492-496;
24. P. Barditch-Crovo, J. Toole, C. W. Hendrix, K. C. Cundy, D. Ebeling, H. S. Jaffe, P. S. Lietman, J. Infect. Dis. 1997, 176, 406-413.
25. J. Rautio, H. Kumpulainen, T. Heimbach, R. Oliyai, D. Oh, T. Jarvinen, J. Savolainen, Nat. Rev. Drug Discovery 2008, 7, 255-270.
26. J. Balzarini, A. Holy, J. Jindrich, L. Naesens, R. Snoeck, D. Schols, E. DeClercq, Antimicrob. Agents Chemother. 1993, 37, 332-338;
27. E. DeClercq, Antiviral Res. 2007, 75, 1-13.
28. L. L. Siu, D. D. VonHoff, A. Rephaeli, E. Izbicka, C. Cerna, L. Gomez, E. K. Rowinsky, S. G. Eckhardt, Invest. New Drugs 1998, 16, 113-119;
29. T. Reid, F. Valone, W. Lipera, D. Irwin, W. Paroly, R. Natale, S. Sreedharan, H. Keer, B. Lum, F. Scappaticci, A. Bhatnagar, Lung Cancer 2004, 45, 381-386.
30. N. Korsisaari, D. J. Rossi, K. Luukko, K. Huebner, M. Henkemeyer, T. P. Makela, Mol. Cell. Biol. 2003, 23, 3929-3935.
31. T. W. Abraham, C. R. Wagner, Nucleosides Nucleotides 1994, 13, 1891-1903;
32. E. J. McIntee, R. P. Remmel, R. F. Schinazi, T. W. Abraham, C. R. Wagner, J. Med. Chem. 1997, 40, 3323-3331.
33. T. W. Abraham, T. I. Kalman, E. J. McIntee, C. R. Wagner, J. Med. Chem. 1996, 39, 4569-4575.
34. O. Adelfinskaya, P. Herdewijn, Angew. Chem. 2007, 119, 4434-4436; Angew. Chem. Int. Ed. 2007, 46, 4356-4358.
35. M. Maiti, S. Michielssens, N. Dyubankova, M. Maiti, E. Lescrinier, A. Ceulemans, P. Herdewijn, Chem. Eur. J. 2012, 18, 857-868.
36. A. C. Benniston, P. Gunning, R. D. Peacock, J. Org. Chem. 2005, 70, 115-123.
37. B. P. Bandgar, R. J. Sarangdhar, S. Viswakarma, F. A. Ahamed, J. Med. Chem. 2011, 54, 1191-1201.
38. Y. Feng, J. K. Coward, J. Med. Chem. 2006, 49, 770-788.
39. D. M. Lehsten, D. N. Baehr, T. J. Lobl, A. R. Vaino, Org. Process Res. Dev. 2002, 6, 819-822.
40. C. McGuigan, R. N. Pathirana, N. Mahmood, K. G. Devine, A. J. Hay, Antiviral Res. 1992, 17, 311-321;
41. C. McGuigan, R. N. Pathirana, J. Balzarini, E. DeClercq, J. Med. Chem. 1993, 36, 1048-1052.
42. Y. Mizuno, T. Itoh, K. Saito, Chem. Pharm. Bull. 1964, 12, 866-872;
43. F. Seela, H. Rosemeyer, S. Fischer, Helv. Chim. Acta 1990, 73, 1602-1611;
44. C. Crey-Desbiolles, J. Lhomme, P. Dumy, M. Kotera, J. Am. Chem. Soc. 2004, 126, 9532-9533.
45. E. P. Brass, Pharmacol. Rev. 2002, 54, 589-598.
46. S. Vittori, D. DalBen, C. Lambertucci, G. Marucci, R. Volpini, G. Cristalli, Curr. Med. Chem. 2006, 13, 3529-3552.
47. M. J. Sofia, W. S. Chang, P. A. Furman, R. T. Mosley, B. S. Ross, J. Med. Chem. 2012, 55, 2481-2531.
48. M. Derudas, D. Carta, A. Brancale, C. Vanpouille, A. Lisco, L. Margolis, J. Balzarini, C. McGuigan, J. Med. Chem. 2009, 52, 5520-5530;
49. C. McGuigan, P. Murziani, M. Slusarczyk, B. Gonczy, J. VandeVoorde, S. Liekens, J. Balzarini, J. Med. Chem. 2011, 54, 7247-7258.